Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified), Unconjugated

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified), Unconjugated
• Artikelnummer: ABS-SPD-M265-1MG
• Hersteller Artikelnummer: SPD-M265-1mg
• Alternativnummer: ABS-SPD-M265-1MG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

The antibody is isolated from the serum of COVID19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARSCoV2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and O

Produkteigenschaften

• Tag: Human IgG1 | Human Kappa
• Puffer: PBS, pH7.4
• Quelle: The antibody is isolated from the serum of COVID-19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARS-CoV-2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron
• Expression System: HEK293
• Reinheit: 95%
• Formulierung: Powder
• Target-Kategorie: Spike RBD
• Antibody Type: Recombinant Antibody

Bilder

SPD-M265-1mg